No takes yet. Share an insight, caveat, or question.
Policy review reveals critical validation and financing gaps for rapid diagnostic tests during outbreaks, highlighting the need to align diagnostic investment with vaccine development.
Yimer et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: